London Daily

Focus on the big picture.
Thursday, Oct 02, 2025

To vaccinate children or not? Getting decision right is far from child’s play

To vaccinate children or not? Getting decision right is far from child’s play

The JCVI is under pressure from ministers to make a decision over booster jabs and vaccines for 12- to 15-year-olds
It is a mantra heard less often these days, that the government will “follow the science” over Covid, and for good reason. As current uncertainty over the UK’s vaccine programme shows, there are times when science and politics can lead you in very different directions.

NHS England is preparing for the rollout of both third “booster” Covid vaccines and to extend vaccinations to the bulk of 12- to 15-year-olds, while the Department of Health and Social Care (DHSC) hopes one or both these will begin in early September.

There is just one issue: the government’s vaccines watchdog, to which ministers have very publicly devolved all decisions on such matters, has not yet made up its mind on the programmes, and some members dismiss the September deadline as wildly unrealistic.

While no ministers have gone on the record yet, it is known that with Covid infections creeping up, and predictions they will rocket amid the social petri dish of pupils returning to English schools next week, some officials are getting a bit anxious.

Currently only 12- to 15-year-olds with clinical vulnerabilities, or those who live with those at risk, get jabbed, and the government’s Joint Committee on Vaccination and Immunisation (JCVI) has yet to decide if this should be extended to others in this age group, despite this already happening in the US and several other European countries.

“JCVI is very much towards the end of the pack in making this decision,” one official said.

“You want to be going into autumn having done everything you could. It’s not always clear why we haven’t already got a decision on some things which are moving forward in other countries, and are clearly things where there’s a good case for doing them.”

In a sign of ministerial keenness to start widespread vaccinations of 12- to 15-year-olds, the DHSC announced it had formally asked the NHS to prepare for this from early September, pending JCVI approval, “to be ready to hit the ground running”. It said the NHS was preparing a “school-based programme” of jabs.

The political and even public health imperative might seem clear. But as with several issues connected to vaccines, it is more complex than it might first appear.

One issue is whether it is right to, effectively, give vaccines to children to protect others. While people of that age can become seriously ill or develop long Covid it is very rare, so the primary benefit of school vaccinations is to prevent young people transmitting the virus to others who are more vulnerable.

This might seem arcane, even philosophical, but it is a core tenet of public health, to consider individual risk versus community gain, and some JCVI members are known to want further research into the potential side-effects of vaccines on young people.

“Clearly the benefits in harm reduction from Covid for adults is very clearly in favour of vaccination, but the harm reduction is much less for children,” said Stephen Evans, an expert on the safety of medicines at the London School of Hygiene & Tropical Medicine.

“Children only very rarely have severe Covid disease so you need to be very sure that they do not have adverse effects that are also very rare, but would alter the risk and benefit for them, and not just take into account any apparent benefit to the community.”

Another issue is any potential impact on wider vaccination programmes for other diseases, which have seen levels fall amid the pandemic. This could be affected both by a form of “vaccine fatigue”, especially if someone has a reaction to a Covid jab, but also through the concentration of finite vaccination resources on the one health issue.

One scientist said that while jabs for clinically vulnerable 12- to 15-year-olds were taking place in vaccination hubs, a wider programme would probably need to happen in schools, given factors such as the different training needed to vaccinate children, who are, among other differences, more likely to faint.

Recently released JCVI minutes showed this week that the number of teenagers in England getting vaccinated against some cancers, meningitis, septicaemia and other fatal conditions fell by 20% after the first lockdown last year.

The scientist said: “Dying of vaccine-preventable oro-genital cancer in 30 years’ time or meningococcal septicaemia in freshers’ week would not show in Covid mortality figures. However it is very much the role of JCVI to pay attention to such wider vaccine-related issues.”

There are similar complications with the JCVI’s considerations on booster vaccinations, which are expected to be rolled out for clinically extremely vulnerable adults, for whom vaccine effectiveness is lowered, and potentially more widely.

While Israel has already begun a general programme of such injections, the JCVI has yet to decide how to proceed, and is waiting for the results of various clinical trials.

The delay is sometimes portrayed as indicating splits within the JCVI, but one source said this was simply a case of “outside armchair experts asking seemingly simple questions that are in fact significantly complex”.

But one thing seems clear: with infection rates in Scotland rising quickly after the return of schools – although scientists say it is too early to make a definitive connection – as the start of English term looms, the pressure from ministers, however polite, will not go away.

One official said that while there was no thought of ministers going ahead with any vaccinations without a formal JCVI go-ahead, “we do want them to come to a conclusion”.

Another said: “I’m sure the JCVI are well aware of this, but they also need to weigh up the timing of the decision. It’s not a PhD thesis which can go on for years. It’s a real-world thing.”
Newsletter

Related Articles

0:00
0:00
Close
Trump Administration Launches “TrumpRx” Plan to Enable Direct Drug Sales at Deep Discounts
Trump Announces Intention to Impose 100 Percent Tariff on Foreign-Made Films
Altman Says GPT-5 Already Outpaces Him, Warns AI Could Automate 40% of Work
Singapore and Hong Kong Vie to Dominate Asia’s Rising Gold Trade
Trump Organization Teams with Saudi Developer on $1 Billion Trump Plaza in Jeddah
Manhattan Sees Surge in Office-to-Housing Conversions, Highest Since 2008
Switzerland and U.S. Issue Joint Assurance Against Currency Manipulation
Electronic Arts to Be Taken Private in Historic $55 Billion Buyout
Thomas Jacob Sanford Named as Suspect in Deadly Michigan Church Shooting and Arson
Russian Research Vessel 'Yantar' Tracked Mapping Europe’s Subsea Cables, Raising Security Alarms
New York Man Arrested After On-Air Confession to 2017 Parents’ Murders
U.S. Defense Chief Orders Sudden Summit of Hundreds of Generals and Admirals
Global Cruise Industry Posts Dramatic Comeback with 34.6 Million Passengers in 2024
Trump Claims FBI Planted 274 Agents at Capitol Riot, Citing Unverified Reports
India: Internet Suspended in Bareilly Amid Communal Clashes Between Muslims and Hindus
Supreme Court Extends Freeze on Nearly $5 Billion in U.S. Foreign Aid at Trump’s Request
Archaeologists Recover Statues and Temples from 2,000-Year-Old Sunken City off Alexandria
China Deploys 2,000 Workers to Spain to Build Major EV Battery Factory, Raising European Dependence
Speed Takes Over: How Drive-Through Coffee Chains Are Rewriting U.S. Coffee Culture
U.S. Demands Brussels Scrutinize Digital Rules to Prevent Bias Against American Tech
Ringo Starr Champions Enduring Beatles Legacy While Debuting Las Vegas Art Show
Private Equity’s Fundraising Surge Triggers Concern of European Market Shake-Out
Colombian President Petro Vows to Mobilize Volunteers for Gaza and Joins List of Fighters
FBI Removes Agents Who Kneeled at 2020 Protest, Citing Breach of Professional Conduct
Trump Alleges ‘Triple Sabotage’ at United Nations After Escalator and Teleprompter Failures
Shock in France: 5 Years in Prison for Former President Nicolas Sarkozy
Tokyo’s Jimbōchō Named World’s Coolest Neighbourhood for 2025
European Officials Fear Trump May Shift Blame for Ukraine War onto EU
BNP Paribas Abandons Ban on 'Controversial Weapons' Financing Amid Europe’s Defence Push
Typhoon Ragasa Leaves Trail of Destruction Across East Asia Before Making Landfall in China
The Personality Rights Challenge in India’s AI Era
Big Banks Rebuild in Hong Kong as Deal Volume Surges
Italy Considers Freezing Retirement Age at 67 to Avert Scheduled Hike
Italian City to Impose Tax on Visiting Dogs Starting in 2026
Arnault Denounces Proposed Wealth Tax as Threat to French Economy
Study Finds No Safe Level of Alcohol for Dementia Risk
Denmark Investigates Drone Incursion, Does Not Rule Out Russian Involvement
Lilly CEO Warns UK Is ‘Worst Country in Europe’ for Drug Prices, Pulls Back Investment
Nigel Farage Emerges as Central Force in British Politics with Reform UK Surge
Disney Reinstates ‘Jimmy Kimmel Live!’ after Six-Day Suspension over Charlie Kirk Comments
U.S. Prosecutors Move to Break Up Google’s Advertising Monopoly
Nvidia Pledges Up to $100 Billion Investment in OpenAI to Power Massive AI Data Center Build-Out
U.S. Signals ‘Large and Forceful’ Support for Argentina Amid Market Turmoil
Nvidia and Abu Dhabi’s TII Launch First AI-&-Robotics Lab in the Middle East
Vietnam Faces Up to $25 Billion Export Loss as U.S. Tariffs Bite
Europe Signals Stronger Support for Taiwan at Major Taipei Defence Show
Indonesia Court Upholds Military Law Amid Concerns Over Expanded Civilian Role
Larry Ellison, Michael Dell and Rupert Murdoch Join Trump-Backed Bid to Take Over TikTok
Trump and Musk Reunite Publicly for First Time Since Fallout at Kirk Memorial
Vietnam Closes 86 Million Untouched Bank Accounts Over Biometric ID Rules
×